Patent · US Active

Antagonists of the muscarinic acetylcholine receptor M4

US11325896B2 · kind B2 · utility

0Cited by
3References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2018
Grant dateMay 10, 2022
Priority date
Expiry dateDec 20, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed herein are substituted 2-azaspiro[3.3]heptane compounds of formula (I′), which may be useful as antagonists of the muscarinic acetylcholine receptor M4 (mAChR M4). Also disclosed herein are methods of making the compounds, pharmaceutical compositions comprising the compounds, and methods of treating disorders using the compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.